Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells

This publication has 12 references indexed in Scilit:

• A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells
  Oncogene, 1997
• Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
  Nature Medicine, 1997
• Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents
  Nature Medicine, 1996
• Mice Lacking p27 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors
  Cell, 1996
• Inhibitors of mammalian G1 cyclin-dependent kinases.
  Genes & Development, 1995
• Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cells
  Cancer Letters, 1994
• Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
  Cell, 1994
• Drug and radiation resistance in spheroids: cell contact and kinetics
  Cancer and Metastasis Reviews, 1994
• Confluence‐dependent resistance in human colon cancer cells: Role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells
  International Journal of Cancer, 1992
• In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell line
  Gynecologic Oncology, 1991